157 related articles for article (PubMed ID: 38455966)
1. Exploiting the damaging effects of ROS for therapeutic use by deactivating cell-free chromatin: the alchemy of resveratrol and copper.
Mittra I
Front Pharmacol; 2024; 15():1345786. PubMed ID: 38455966
[TBL] [Abstract][Full Text] [Related]
2. A pro-oxidant combination of resveratrol and copper down-regulates multiple biological hallmarks of ageing and neurodegeneration in mice.
Pal K; Raghuram GV; Dsouza J; Shinde S; Jadhav V; Shaikh A; Rane B; Tandel H; Kondhalkar D; Chaudhary S; Mittra I
Sci Rep; 2022 Oct; 12(1):17209. PubMed ID: 36241685
[TBL] [Abstract][Full Text] [Related]
3. A pro-oxidant combination of resveratrol and copper reduces chemotherapy-related non-haematological toxicities in advanced gastric cancer: results of a prospective open label phase II single-arm study (RESCU III study).
Ostwal V; Ramaswamy A; Bhargava P; Srinivas S; Mandavkar S; Chaugule D; Peelay Z; Baheti A; Tandel H; Jadhav VK; Shinde S; Jadhav S; Gota V; Mittra I
Med Oncol; 2022 Nov; 40(1):17. PubMed ID: 36372825
[TBL] [Abstract][Full Text] [Related]
4. A pro-oxidant combination of resveratrol and copper down-regulates hallmarks of cancer and immune checkpoints in patients with advanced oral cancer: Results of an exploratory study (RESCU 004).
Pilankar A; Singhavi H; Raghuram GV; Siddiqui S; Khare NK; Jadhav V; Tandel H; Pal K; Bhattacharjee A; Chaturvedi P; Mittra I
Front Oncol; 2022; 12():1000957. PubMed ID: 36185249
[TBL] [Abstract][Full Text] [Related]
5. Cell-free chromatin particles released from dying cells inflict mitochondrial damage and ROS production in living cells.
Raghuram GV; Tripathy BK; Avadhani K; Shabrish S; Khare NK; Lopes R; Pal K; Mittra I
Cell Death Discov; 2024 Jan; 10(1):30. PubMed ID: 38225229
[TBL] [Abstract][Full Text] [Related]
6. Cell-free chromatin particles released from dying cancer cells activate immune checkpoints in human lymphocytes: implications for cancer therapy.
Shabrish S; Pal K; Khare NK; Satsangi D; Pilankar A; Jadhav V; Shinde S; Raphael N; Sriram G; Lopes R; Raghuram GV; Tandel H; Mittra I
Front Immunol; 2023; 14():1331491. PubMed ID: 38274821
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic interventions on human breast cancer xenografts promote systemic dissemination of oncogenes.
Raghuram GV; Pal K; Sriram G; Khan A; Joshi R; Jadhav V; Shinde S; Shaikh A; Rane B; Kangne H; Mittra I
PLoS One; 2024; 19(2):e0298042. PubMed ID: 38346047
[TBL] [Abstract][Full Text] [Related]
8. Antioxidant vs. Prooxidant Properties of the Flavonoid, Kaempferol, in the Presence of Cu(II) Ions: A ROS-Scavenging Activity, Fenton Reaction and DNA Damage Study.
Simunkova M; Barbierikova Z; Jomova K; Hudecova L; Lauro P; Alwasel SH; Alhazza I; Rhodes CJ; Valko M
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562744
[TBL] [Abstract][Full Text] [Related]
9. Cell-free chromatin particles released from dying host cells are global instigators of endotoxin sepsis in mice.
Mittra I; Pal K; Pancholi N; Tidke P; Siddiqui S; Rane B; D'souza J; Shaikh A; Parab S; Shinde S; Jadhav V; Shende S; Raghuram GV
PLoS One; 2020; 15(3):e0229017. PubMed ID: 32130239
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of novel coumarin nucleus-based DPA drug-like molecular entity: In vitro DNA/Cu(II) binding, DNA cleavage and pro-oxidant mechanism for anticancer action.
Khan S; Malla AM; Zafar A; Naseem I
PLoS One; 2017; 12(8):e0181783. PubMed ID: 28763458
[TBL] [Abstract][Full Text] [Related]
11. Antitumor activity of resveratrol is independent of Cu(II) complex formation in MCF-7 cell line.
Andrade Volkart P; Benedetti Gassen R; Mühlen Nogueira B; Nery Porto B; Eduardo Vargas J; Arigony Souto A
Bioorg Med Chem Lett; 2017 Aug; 27(15):3238-3242. PubMed ID: 28647350
[TBL] [Abstract][Full Text] [Related]
12. A novel pro-oxidant combination of resveratrol and copper reduces transplant related toxicities in patients receiving high dose melphalan for multiple myeloma (RESCU 001).
Agarwal A; Khandelwal A; Pal K; Khare NK; Jadhav V; Gurjar M; Punatar S; Gokarn A; Bonda A; Nayak L; Kannan S; Gota V; Khattry N; Mittra I
PLoS One; 2022; 17(2):e0262212. PubMed ID: 35120140
[TBL] [Abstract][Full Text] [Related]
13. Copper-redox cycling by coumarin-di(2-picolyl)amine hybrid molecule leads to ROS-mediated DNA damage and apoptosis: A mechanism for cancer chemoprevention.
Khan S; Zafar A; Naseem I
Chem Biol Interact; 2018 Jun; 290():64-76. PubMed ID: 29803612
[TBL] [Abstract][Full Text] [Related]
14. The role of redox active copper(II) on antioxidant properties of the flavonoid baicalein: DNA protection under Cu(II)-Fenton reaction and Cu(II)-ascorbate system conditions.
Jomova K; Cvik M; Lauro P; Valko M; Cizmar E; Alomar SY; Alwasel SH; Oleksak P; Chrienova Z; Nepovimova E; Kuca K; Rhodes CJ
J Inorg Biochem; 2023 Aug; 245():112244. PubMed ID: 37178556
[TBL] [Abstract][Full Text] [Related]
15. Prevention of chemotherapy toxicity by agents that neutralize or degrade cell-free chromatin.
Mittra I; Pal K; Pancholi N; Shaikh A; Rane B; Tidke P; Kirolikar S; Khare NK; Agrawal K; Nagare H; Nair NK
Ann Oncol; 2017 Sep; 28(9):2119-2127. PubMed ID: 28911066
[TBL] [Abstract][Full Text] [Related]
16. Cu(II)-coumestrol interaction leads to ROS-mediated DNA damage and cell death: a putative mechanism for anticancer activity.
Zafar A; Singh S; Naseem I
J Nutr Biochem; 2016 Jul; 33():15-27. PubMed ID: 27260464
[TBL] [Abstract][Full Text] [Related]
17. Copper-induced oxidative stress in rainbow trout gill cells.
Bopp SK; Abicht HK; Knauer K
Aquat Toxicol; 2008 Jan; 86(2):197-204. PubMed ID: 18063143
[TBL] [Abstract][Full Text] [Related]
18. The effect of Luteolin on DNA damage mediated by a copper catalyzed Fenton reaction.
Jomova K; Hudecova L; Lauro P; Simunková M; Barbierikova Z; Malcek M; Alwasel SH; Alhazza IM; Rhodes CJ; Valko M
J Inorg Biochem; 2022 Jan; 226():111635. PubMed ID: 34717250
[TBL] [Abstract][Full Text] [Related]
19. Copper(II) generates ROS and RNS, impairs antioxidant system and damages membrane and DNA in human blood cells.
Husain N; Mahmood R
Environ Sci Pollut Res Int; 2019 Jul; 26(20):20654-20668. PubMed ID: 31104239
[TBL] [Abstract][Full Text] [Related]
20. Cancer Pro-oxidant Therapy Through Copper Redox Cycling:
Rieber M
Curr Pharm Des; 2020; 26(35):4461-4466. PubMed ID: 32600223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
